To test whether CASC11 regulates the stability of UBE2T mRNA, HCC cells with CASC11 knockdown or overexpression were treated with Actinomycin D to block new RNA synthesis, before the loss of UBE2T mRNA was measured in different time points. The gene discussed is CASC11; the disease is hepatocellular carcinoma.